These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9772323)

  • 21. Compliance of Austrian tourists with prophylactic measures.
    Kollaritsch H; Wiedermann G
    Eur J Epidemiol; 1992 Mar; 8(2):243-51. PubMed ID: 1644143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis.
    Färnert A; Tengstam K; Palme IB; Bronner U; Lebbad M; Swedberg G; Björkman A
    Am J Trop Med Hyg; 2002 May; 66(5):487-91. PubMed ID: 12201581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria prophylaxis in travellers to tropical Africa.
    Weinke T; Weber G; Schultes U; Hopfenmüller W; Janitschke K
    Klin Wochenschr; 1990 Mar; 68(5):277-80. PubMed ID: 2182940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria deaths following inappropriate malaria chemoprophylaxis--United States, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jul; 50(28):597-9. PubMed ID: 11476528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge of malaria, risk perception, and compliance with prophylaxis and personal and environmental preventive measures in travelers exiting Zimbabwe from Harare and Victoria Falls International airport.
    Laver SM; Wetzels J; Behrens RH
    J Travel Med; 2001; 8(6):298-303. PubMed ID: 11726294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mefloquine for malaria chemoprophylaxis 1992-1998: a review.
    Schlagenhauf P
    J Travel Med; 1999 Jun; 6(2):122-33. PubMed ID: 10381965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antenatal chloroquine chemoprophylaxis in Malawi: chloroquine resistance, compliance, protective efficacy and cost.
    Heymann DL; Steketee RW; Wirima JJ; McFarland DA; Khoromana CO; Campbell CC
    Trans R Soc Trop Med Hyg; 1990; 84(4):496-8. PubMed ID: 2091336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malaria Surveillance - United States, 2014.
    Mace KE; Arguin PM
    MMWR Surveill Summ; 2017 May; 66(12):1-24. PubMed ID: 28542123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of malaria in British residents returning from malarious areas.
    Phillips-Howard PA; Radalowicz A; Mitchell J; Bradley DJ
    BMJ; 1990 Feb; 300(6723):499-503. PubMed ID: 2107927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malaria--chemoprophylaxis 2001].
    Hatz FR; Beck B; Blum J; Funk M; Furrer H; Genton B; Holzer B; Loutan L; Markwalder K; Raeber PA; Schlagenhauf P; Siegl G; Steffen R; Stürchler D; Wyss R
    Ther Umsch; 2001 Jun; 58(6):347-51. PubMed ID: 11441694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
    Carme B; Péguet C; Nevez G
    Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ; Koene HR; Spong K; Overbosch D
    J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
    J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis.
    Hoebe C; de Munter J; Thijs C
    Eur J Clin Pharmacol; 1997; 52(4):269-75. PubMed ID: 9248763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unreliability of saliva samples for monitoring chloroquine and proguanil levels during anti-malarial chemoprophylaxis.
    Rault JP; Hasselot N; Renard C; Cheminel V; Chaulet JF
    Gen Pharmacol; 1996 Jan; 27(1):65-7. PubMed ID: 8742495
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.
    Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E
    J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa.
    Fontanet AL; Houzé S; Keundjian A; Schiemann R; Ralaimazava P; Durand R; Cha O; Coulaud JP; Le Bras J; Bouchaud O
    Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):91-100. PubMed ID: 15607335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malaria chemoprophylaxis.
    Stek M
    Postgrad Med; 1980 Feb; 67(2):121-31. PubMed ID: 6986044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.